Your browser doesn't support javascript.
loading
The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.
Fackche, Nadege; Schmocker, Ryan K; Kubi, Boateng; Cloyd, Jordan M; Ahmed, Ahmed; Grotz, Travis; Leiting, Jennifer; Fournier, Keith; Lee, Andrew J; Powers, Benjamin; Dineen, Sean; Veerapong, Jula; Baumgartner, Joel M; Clarke, Callisia; Gamblin, T Clark; Patel, Sameer H; Dhar, Vikrom; Hendrix, Ryan J; Lambert, Laura; Abbott, Daniel E; Pokrzywa, Courtney; Lafaro, Kelly; Lee, Byrne; Zaidi, Mohammad Y; Maithel, Shishir K; Johnston, Fabian M; Greer, Jonathan B.
Affiliation
  • Fackche N; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University, Baltimore, MD, USA.
  • Schmocker RK; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University, Baltimore, MD, USA.
  • Kubi B; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University, Baltimore, MD, USA.
  • Cloyd JM; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Ahmed A; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Grotz T; Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, MN, USA.
  • Leiting J; Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, MN, USA.
  • Fournier K; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee AJ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Powers B; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Department of Oncologic Sciences, Morsani College of Medicine, Tampa, FL, USA.
  • Dineen S; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Department of Oncologic Sciences, Morsani College of Medicine, Tampa, FL, USA.
  • Veerapong J; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.
  • Baumgartner JM; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.
  • Clarke C; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Gamblin TC; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Patel SH; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Dhar V; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Hendrix RJ; Division of Surgical Oncology, Department of Surgery, University of Massachusetts Medical School, Worcester, MA, USA.
  • Lambert L; Division of Surgical Oncology, Department of Surgery, University of Massachusetts Medical School, Worcester, MA, USA.
  • Abbott DE; Division of Surgical Oncology, Department of Surgery, University of Wisconsin, Madison, WI, USA.
  • Pokrzywa C; Division of Surgical Oncology, Department of Surgery, University of Wisconsin, Madison, WI, USA.
  • Lafaro K; Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, South Pasadena, CA, USA.
  • Lee B; Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, South Pasadena, CA, USA.
  • Zaidi MY; Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Maithel SK; Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Johnston FM; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University, Baltimore, MD, USA.
  • Greer JB; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University, Baltimore, MD, USA. jgreer13@jhmi.edu.
J Gastrointest Surg ; 25(11): 2908-2919, 2021 11.
Article in En | MEDLINE | ID: mdl-33634422
BACKGROUND: Prognostication based on preoperative clinical factors is lacking in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). This study aims to determine the value of preoperative tumor markers as predictors of progression-free survival (PFS) and overall survival (OS) for patients with peritoneal carcinomatosis from a primary mucinous adenocarcinoma of the appendix (MACA). METHODS: We queried the United States HIPEC Collaborative, a database of patients with peritoneal carcinomatosis treated with CRS/HIPEC at twelve institutions between 2000 and 2017, identifying 409 patients with MACA. Multivariate analysis was used to identify independent predictors of disease progression. Subgroup analysis was conducted to evaluate the impact of tumor grade on the predictive value of tumor markers. RESULTS: CA19-9 [HR 2.44, CI 1.2-3.4] emerged as an independent predictor of PFS while CEA [HR 4.98, CI 1.06-23.46] was independently predictive of OS (p <0.01). Tumor differentiation was the most potent predictor of both PFS (poorly differentiated vs well, [HR 4.5 CI 2.01-9.94]) and OS ([poorly differentiated vs well-differentiated: [HR 13.5, CI 3.16-57.78]), p <0.05. Among patients with combined CA19-9 elevation and poorly differentiated histology, 86% recurred within a year of CRS/HIPEC (p < 0.01). Similarly, the coexistence of CEA elevation and unfavorable histology led to the lowest survival rate at two years [36%, p < 0.01]. CA-125 was not predictive of PFS or OS. CONCLUSION: Elevated preoperative CA19-9 portends worse PFS, while elevated CEA predicts worse OS after CRS/HIPEC in patients with MACA. This study provides additional evidence that CA19-9 and CEA levels should be collected during standard preoperative bloodwork, while CA-125 can likely be omitted. Tumor differentiation, when added to preoperative tumor marker levels, provides powerful prognostic information. Prospective studies are required to confirm this association.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Appendiceal Neoplasms / Appendix / Peritoneal Neoplasms / Adenocarcinoma / Hyperthermia, Induced Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Gastrointest Surg Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Appendiceal Neoplasms / Appendix / Peritoneal Neoplasms / Adenocarcinoma / Hyperthermia, Induced Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Gastrointest Surg Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: United States